BioSpace News Archive

CareDx, Inc. today announced that its non-invasive organ transplant surveillance solutions are being used to help monitor post-operative graft health in the world’s first successful heart xenotransplantation.

Oyster Point Pharma, Inc. (Nasdaq: OYST), (“Oyster Point Pharma”, or “the Company”), today announced TYRVAYATM Nasal Spray’s placement on the Express Scripts National Preferred, Basic, and High Performance Formularies, which collectively makes up an estimated 26 million lives, effective February 19, 2022.

Athira Pharma, Inc. today announced that preclinical data for the active metabolite of fosgonimeton and Athira’s new oral small molecule, ATH-1020, will be presented in two oral presentations at the American Society for Experimental Neurotherapeutics (ASENT) Annual Meeting, taking place virtually, Feb. 28 - March 3, 2022.

Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and slow neurodegeneration, today announced the peer-reviewed publication of data from a Phase 1 clinical trial of fosgonimeton (ATH-1017) in The Journal of Alzheimer’s Disease.

Albireo Pharma, Inc. announced that the National Institute for Health and Care Excellence has issued guidance that recommends Bylvay for the treatment of all types of progressive familial intrahepatic cholestasis in people aged six months and older.

Bio-Techne Corporation announced an agreement with Thermo Fisher Scientific to exclusively complete development of and commercialize the ExoTRU kidney transplant rejection test developed by Exosome Diagnostics, a Bio-Techne brand.

Zimmer Biomet Holdings, Inc., a global medical technology leader, announced that its Board of Directors has approved the payment of a quarterly cash dividend to stockholders for the first quarter of 2022.

MicroVention, Inc., a subsidiary of Terumo and a global neurovascular company, announced the first U.S. clinical case of its next generation Flow Diverter, the FRED X device, at Thomas Jefferson University Hospital located in Philadelphia.

NuVasive, Inc. announced that Chief Executive Officer Chris Barry will virtually present at the 42nd Annual Cowen Healthcare Conference on Tuesday, March 8, 2022 at 8:10 a.m. PT / 11:10 a.m. ET.

Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC) today announced that it will host a conference call and webcast on Thursday, March 3, 2022, at 5:00 p.m. ET to discuss a corporate update and financial results for the fourth quarter and full year 2021.